COVID-19 Coverage


The Pandemic of 2020

Timmerman Report articles about the coronavirus pandemic are being made free for everyone. It’s a public health emergency. This in-depth reporting and fact-based analysis should be widely available, not just for biopharmaceutical professionals who are paying subscribers.

Timmerman Report is an independent subscription publication founded in 2015. It’s for anyone who seeks to understand new drug development, diagnostics, genomics, and technologies changing medicine.

TR Coverage of the Pandemic




  • COVID-19 Testing Needs to Be Open, Not Closed. Sept. 30. (Alex Dickinson)
  • What We Know and What We Don’t. Sept. 21. (Alex Harding)
  • Moderna & Pfizer Transparency & a Tribute to Bill Gates Sr. Sept. 17. (Luke Timmerman)
  • Industry and Academia Take a Stand for Science. Sept. 10 (Luke Timmerman)
  • FDA and CDC Credibility Tarnished; Pfizer Sprints Ahead With Vaccine. Sept. 3. (Luke Timmerman)




  • Q&A With Regeneron on Neutralizing Antibodies. June 29. (KJ Mulam)
  • How the US is Losing Against the Virus. June 26. (Otello Stampacchia)
  • The Exponential Curves Re-Emerge. June 26. (Luke Timmerman)
  • Inconvenient Truths and Rays of Light. June 11. (Luke Timmerman)
  • Making Drugs at the Edge of Reason. June 10. (Vicki Sato)
  • Anger, Pain and Hope. June 4. (Luke Timmerman)
  • Puretech Focuses on Long-Term Lung Complications in COVID19 Patients. June 2. (KJ Mulam)
  • Dig Deep and Fight Hard Against Injustice. June 1. (Rob Perez)



  • Tracking Viral Outbreaks. Emma Hodcroft on The Long Run. Apr. 30. (Luke Timmerman)
  • Keeping an Academic Lab Afloat. Apr. 28. (Jim Olson)
  • We Didn’t Become the World Biotech Leader By Sealing Ourselves Off. Apr. 28. (Bernat Olle)
  • Capturing Family History, While We Have Time. Apr. 27. (Leora Schiff)
  • How a Gesture Morphed Into a Full-Time Effort to Feed the Frontline. Apr. 27. (Ellen Kuwana)
  • A San Francisco Doctor Answers the Call to NYC. Apr. 25. (Ethan Weiss)
  • A Sad Week of Reckless Leadership. Apr. 24. (Luke Timmerman)
  • Build Back Better. Apr. 22. (David Shaywitz)
  • Massachusetts Biotechs Consider How to Return Safely. Apr. 22. (Adam Thomas)
  • How to Navigate a Blizzard of Antibody Studies. Apr. 21. (Ruth Etzioni)
  • Singapore Forgot to Check Its Blind Spot. Apr. 21. (Carolyn Ng)
  • Cultivating a Tolerance for Adversity in Our Teams. Apr. 20. (Eric Murphy)
  • The Real Question is How to Restart. Apr. 17. (Otello Stampacchia)
  • Walking the Diagnostic and Serologic Testing Tightrope. Apr. 17. (Ruth Etzioni)
  • Hunting for Antibodies: George Scangos on The Long Run. Apr. 17 (Luke Timmerman)
  • Bridging the Social Divide in the Pandemic. Apr. 17. (Dr. Alex Harding)
  • Serology Testing: Keep an Eye Out for Quick-and-Dirty Tests. Apr. 16. (Michael Koeris)
  • Scaling Up Antibodies and Vaccines Won’t Be Easy. Apr. 16. (Jim Thomas)
  • Don’t Waste This Crisis: Solving the Patient Cost-Share Problem. Apr. 15. (Jeff Berkowitz)
  • Drug Repurposing to Keep COVID19 Patients Out of the ICU. Apr. 15. (Robert Plenge)
  • A Healthcare Investor, and Doctor, Peering into the Fog. Apr. 14. (David Sable)
  • The Pandemic Takes a Certain Kind of Toll on African Americans. Apr. 14. (Stephen Graham)
  • Why COVID-19 Can’t Be Compared With Flu. Apr. 14. (Ruth Etzioni)
  • The Testing Fiasco Continues. Apr. 9. (Luke Timmerman)
  • Facing the Consequences of a Misinformation Pandemic. Apr. 8. (Kyle Serikawa)
  • Rationale for Testing Anticoagulants Against COVID19. Apr. 7. (Ethan Weiss)
  • Not All COVID-19 Models Are Created Equal. Apr. 7. (Ruth Etzioni)
  • I’ve Got a Fund Full of Toilet Paper and I’m Ready to Deal. Apr. 6. (Lisa Suennen)
  • Where the Puck is Going: Serologic Testing. Apr. 6 (Michael Koeris)
  • Loss & Grief During Covid19. Apr. 6. (Dr. Katherine Shear, Laurel Mayer & Jeff Lieberman)
  • Diagnostic Dysfunction: Mike Pellini on The Long Run. Apr. 4. (Luke Timmerman)
  • A Baffling Coronavirus Response. Frontpoints. Apr. 2. (Luke Timmerman)
  • A Chance at Redemption for US Healthcare. Apr. 2. (Leora Schiff)
  • Thinking Ahead: Building a Broad Arsenal Against Infectious Disease. Apr. 1. (Ankit Mahadevia)
  • Building on Our Immunology Understanding, Seeing Reasons for Hope. Apr. 1. (Doug Williams)
  • What’s the Real Risk of Death from COVID19? Apr. 1. (Otello Stampacchia)